Watch Vasculitis 2025: Advances and Controversies on-demand webcast series, recorded from the Vasculitis 2025: Advances and Controversies course. The focus of the education is to review complexities and innovations in the treatment and diagnosis of various forms of vasculitis.
Webcasts
Advances in Treatment
Faculty: Rula Hajj-Ali, MD; Carol Langford, MD, MHS;
Ruoning Ni, MD;
Benjamin Terrier, MD, PhD;
Michael Wechsler, MD, MMSc
Release date: July 10, 2025
Expiration date: July 9, 2027
Estimated Time: 2 hours and 45 minutes
Type: Webcast
Technical Requirements: None
Specialty: rheumatology, allergy/immunology, dermatology, internal medicine, nursing
Release date: July 10, 2025
Expiration date: July 9, 2027
Estimated Time: 45 minutes
Type: Webcast
Technical Requirements: None
Specialty: rheumatology, allergy/immunology, dermatology, internal medicine, nursing
Release date: July 10, 2025
Expiration date: July 9, 2027
Estimated Time: 1 hour and 15 minutes
Type: Webcast
Technical Requirements: None
Specialty: rheumatology, allergy/immunology, dermatology, internal medicine, nursing
Debates in vasculitis
Faculty: Adam Brown, MD;
Tanaz Kermani, MD;
Ali Mehdi, MD, MEd;
Michael Putman, MD, MSCI;
Alexandra Villa-Forte, MD, MPH;
Kinanah Yaseen, MD
Release date: July 10, 2025
Expiration date: July 9, 2027
Estimated Time: 1 hour and 30 minutes
Type: Webcast
Technical Requirements: None
Specialty: rheumatology, allergy/immunology, dermatology, internal medicine, nursing
Series Learning Objectives
- Critically appraise emergent treatment options in small vessel vasculitis and large vessel vasculitis
- Evaluate CNS involvement in vasculitis
- Evaluate current and future landscape of glucocorticoid use in vasculitis management
- Discuss imaging advancement in large vessel vasculitis and other diagnostic modalities in vasculitis
- Appraise the diagnostic modalities in giant cell arteritis
- Evaluate the clinical evidence supporting the use of tocilizumab as a first-line therapy in GCA
- Appraise the role of plasma exchange in ANCA-associated vasculitis
Target Audience
The online series is directed towards rheumatologists, allergists/immunologists, dermatologists, internal medicine physicians, nurse practitioners, nurses, and physician assistants interested in the treatment of vasculitis.
Acknowledgment
The Cleveland Clinic Center for Continuing Education acknowledges educational grants for partial support of this activity from:
AstraZeneca Pharmaceuticals
This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education, Cleveland Clinic’s Department of Rheumatic & Immunologic Diseases, and Cleveland Clinic’s RJ Fasenmyer Center for Clinical Immunology.
